{"id":"https://openalex.org/W2070949427","doi":"https://doi.org/10.3109/00048679809062742","title":"Withdrawal Reactions Associated with Venlafaxine","display_name":"Withdrawal Reactions Associated with Venlafaxine","alternate_titles":[],"publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2070949427","doi":"https://doi.org/10.3109/00048679809062742","mag":"2070949427","pmid":"https://pubmed.ncbi.nlm.nih.gov/9588310"},"language":"en","primary_location":{"id":"doi:10.3109/00048679809062742","doi":"https://doi.org/10.3109/00048679809062742","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00048679809062742","pdf_url":null,"source":{"id":"https://openalex.org/S179943861","display_name":"Australian & New Zealand Journal of Psychiatry","issn_l":"0004-8674","issn":["0004-8674","1440-1614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian &amp; New Zealand Journal of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2070949427"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053082969","display_name":"Gordon Barraclough Parker","orcid":"https://orcid.org/0000-0003-3424-5519","observed_orcids":["https://orcid.org/0000-0003-3424-5519"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gordon Parker","raw_affiliation_strings":["University of New South Wales, and Mood Disorders Unit, Prince Henry Hospital, Sydney Psychiatry Unit, Prince of Wales Hospital, Randwick, New South Wales, 2031, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New South Wales, and Mood Disorders Unit, Prince Henry Hospital, Sydney Psychiatry Unit, Prince of Wales Hospital, Randwick, New South Wales, 2031, Australia","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4210108821"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021602668","display_name":"Jenny Blennerhassett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jenny Blennerhassett","raw_affiliation_strings":["Pharmacy Department, Prince of Wales Hospital, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department, Prince of Wales Hospital, Sydney, Australia","institution_ids":["https://openalex.org/I4210108821"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":2.0549,"has_fulltext":false,"cited_by_count":54,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86984021,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"32","issue":"2","first_page":"291","last_page":"294"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.8970000147819519,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":1.0},{"id":"https://openalex.org/keywords/drug-withdrawal-syndrome","display_name":"drug withdrawal syndrome","score":0.7020000219345093},{"id":"https://openalex.org/keywords/discontinuation-syndrome","display_name":"discontinuation syndrome","score":0.8619999885559082},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/dose-tapering","display_name":"dose tapering","score":0.7409999966621399},{"id":"https://openalex.org/keywords/missed-doses","display_name":"missed doses","score":0.6570000052452087},{"id":"https://openalex.org/keywords/hallucinations","display_name":"hallucinations","score":0.8080000281333923},{"id":"https://openalex.org/keywords/antidepressant-side-effects","display_name":"antidepressant side effects","score":0.5709999799728394},{"id":"https://openalex.org/keywords/headache","display_name":"headache","score":0.3580000102519989},{"id":"https://openalex.org/keywords/dysphoria","display_name":"dysphoria","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9399018883705139},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9363448619842529},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7273634672164917},{"id":"https://openalex.org/C2780421500","wikidata":"https://www.wikidata.org/wiki/Q290620","display_name":"Dysphoria","level":3,"score":0.6591504216194153},{"id":"https://openalex.org/C2776922375","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Withdrawal syndrome","level":2,"score":0.5939591526985168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5576537847518921},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.535004734992981},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5158016681671143},{"id":"https://openalex.org/C2778062832","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Drug withdrawal","level":3,"score":0.4146479368209839},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3480664789676666},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34488093852996826},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3310002088546753},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.22374141216278076},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.08887892961502075},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0828467309474945}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006212","descriptor_name":"Hallucinations","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/00048679809062742","doi":"https://doi.org/10.3109/00048679809062742","is_oa":false,"landing_page_url":"https://doi.org/10.3109/00048679809062742","pdf_url":null,"source":{"id":"https://openalex.org/S179943861","display_name":"Australian & New Zealand Journal of Psychiatry","issn_l":"0004-8674","issn":["0004-8674","1440-1614"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Australian &amp; New Zealand Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:9588310","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9588310","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Australian and New Zealand journal of psychiatry","raw_type":"Case Reports"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W148590339","https://openalex.org/W947657849","https://openalex.org/W1515279996","https://openalex.org/W1973134867","https://openalex.org/W2038826787","https://openalex.org/W2055934488","https://openalex.org/W2056513437","https://openalex.org/W2249461443","https://openalex.org/W2320983364","https://openalex.org/W2327637568","https://openalex.org/W2398659627","https://openalex.org/W2402630593","https://openalex.org/W2404495567","https://openalex.org/W4236038590"],"related_works":["https://openalex.org/W2067524987","https://openalex.org/W2288922809","https://openalex.org/W1967621994","https://openalex.org/W317672763","https://openalex.org/W177183128","https://openalex.org/W2102351104","https://openalex.org/W2399292184","https://openalex.org/W2092967638","https://openalex.org/W2184345403","https://openalex.org/W2011587234"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,71],"aim":[2],"of":[3,46,54,93,126],"this":[4],"paper":[5],"is":[6],"to":[7,20],"describe":[8],"discontinuation":[9,75,105],"syndromes":[10],"associated":[11],"with":[12,109],"abrupt":[13],"and":[14,19,59,78,84,120,122],"tapered":[15],"withdrawal":[16,23,62,86],"fo":[17],"venlafaxine,":[18,110],"document":[21],"that":[22],"symptoms":[24,76],"may":[25,107,123],"occur":[26,108],"after":[27,50,88],"missing":[28,89],"a":[29,43,52,57,60,67,80,90],"single":[30,91],"dose.":[31],"CLINICAL":[32],"PICTURE:":[33],"We":[34],"report":[35],"on":[36],"two":[37],"patients":[38],"prescribed":[39],"venlafaxine.":[40,94],"One":[41],"developed":[42],"broad":[44],"range":[45],"serious":[47],"side":[48],"effects":[49],"reaching":[51],"dose":[53,92],"300":[55],"mg":[56],"day,":[58],"severe":[61,74,104],"syndrome":[63],"(including":[64],"hallucinations)":[65],"during":[66,77],"slow":[68,81],"taper":[69,82],"regime.":[70],"second":[72],"had":[73],"aborting":[79],"regime,":[83],"described":[85],"responses":[87],"CONCLUSIONS:":[95],"As":[96],"for":[97,133],"the":[98,127,135],"short-acting":[99],"selective":[100],"serotonin":[101],"re-uptake":[102],"inhibitors,":[103],"reactions":[106],"seemingly":[111],"marked":[112],"most":[113],"distinctly":[114],"by":[115],"headache,":[116],"nausea,":[117],"fatigue,":[118],"dizziness":[119],"dysphoria,":[121],"make":[124],"cessation":[125],"drug":[128],"extremely":[129],"difficult.":[130],"Two":[131],"strategies":[132],"addressing":[134],"concern":[136],"are":[137],"considered.":[138]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2070949427","counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
